Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop...
inflammatory
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop...
